The International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST), will take place 12-15 May in Dar es Salaam, Tanzania, covering new advances in HIV prevention, treatment, cure, and vaccine research and development (R&D); implementation science; and how science is being translated into impact through an African-led HIV agenda.
AVAC has compiled resources and highlights to support participation and engagement.
AVAC Infographics
For those presenting at INTEREST (as well as anyone interested in tracking the field), AVAC’s latest infographics on the HIV R&D and delivery pipelines are available in an easy-to-use slide format – including lenacapavir for HIV PrEP (LEN) volume commitments, the current landscape of prevention options in development, and the impact of US funding cuts with new data from PEPFAR. We hope these are useful for presentations and discussions at the conference and beyond.
Join AVAC, Access Bridge and Partners at These Sessions of Interest
If you are in Dar es Salaam, be sure to join sessions in which AVAC, Access Bridge, and our partners are involved.
Posters (Wednesday, 13 May and Thursday, 14 May)
- HIV Prevention Research and Development at a Tipping Point: Insights from the 2025 People’s Research Agenda Update by AVAC’s Grace Kumwenda
Identifying key priorities for the HIV prevention research agenda moving forward and informing global advocacy and engagement in R&D in response to the evolving HIV prevention landscape, including recent scientific advances and growing threats posed by funding and political disruptions.
- Getting PrEP Rollout Right This Time: Lessons from the field by Access Bridge’s Catherine Verde Hashim, presented by Wawira Nyagah
Learn from experts how we can improve and accelerate PrEP introduction at every step along the product introduction pathway. Access the full report: Getting PrEP rollout right this time
- Community Led Research on HIV Treatment, Pathogenesis and Prevention among People who use Drugs in Tanzania by Kwame Juma of Tanzania Network of People Who Use Drugs (TaNPUD) and COMPASS
Description forthcoming!
Mini-Oral Abstract (Friday, 15 May)
- Global Forecast of Long-Acting PrEP Need for Key Populations (2025-2030), by Catherine Verde Hashim presented Wawira Nyagah; 12:00-12:24
Understand the need for long-acting PrEP amongst key populations globally and explore which countries have the highest need.
What We’re Watching
The INTEREST 2026 program includes a full list of sessions, including the following, which AVAC is tracking closely (note: all times are local Tanzanian time):
Tuesday, 12 May
- Opening session with welcome addresses from conference chairs, including AVAC Board member Nyaradzo Mgodi, 9:00-10:45
- Special Session 1: Building Africa’s End to End Vaccine R&D and Manufacturing Ecosystem: Achieve Africa’s Vision, Progress, and Roadmap to Sovereignty, 16:15- 17:00
Wednesday, 13 May
- Session 7: HIV Prevention I: Cure and Vaccine, 8:30-9:15
- Session 8: HIV Prevention II: Broadly Neutralizing Antibodies and Gene Therapy, 14:25-15:10
- Session 9: HIV Prevention III: New Prevention Technologies, with AVAC Board members Nyaradzo Mgodi and Linda-Gail Bekker, 16:35-17:20
If you are attending INTEREST 2026 and would like to connect, reach out to the AVAC and Access Bridge teams at [email protected] and [email protected]. And stay up to date on the latest news from AVAC via our newsletters or on LinkedIn.